Coexisting <i>BRAF</i>-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared <i>JAK2</i> Mutation

<div>Skin sample at the time of diagnosis showing histopathological and immunohistochemical features consistent with Langerhans cell histiocytosis. (a) Haematoxylin and eosin staining (100x), and immunohistochemical staining for (b) S100 (100x) and (c) CD1a (100x).</div>

Case Reports in Hematology

fig2

Figure 2

Figure 2: Coexisting <i>BRAF</i>-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared <i>JAK2</i> Mutation 

Case Reports in Hematology

Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation

Figure 2